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The plants of Rhynchosia genus (Leguminosae) are herba-
ceous, commonly climbing or trailing, sometimes woody,
with a woody rootstock.2) There are two hundred species
throughout the tropics and subtropics with the greatest num-
ber in Africa. Some species have attractive seeds, which have
been used as beads. The seeds of R. volubilis LOUR. have
been used as an expectorant in Japanese folk medicine
(Tankiri-Mame).
In the course of our continuing studies on the antiprolifer-
ative principles of higher plant origin, we found that the
MeOH extract of these seeds inhibits the growth of human
gastric adenocarcinoma [MK-1, 50% growth inhibition (GI50):
25 mg/ml], human uterus carcinoma (HeLa, GI50: 30 mg/ml),
and murine melanoma (B16F10, GI50: 8 mg/ml) cells. These
results led to our interest in the investigation of the chemical
constituents of the MeOH extract. This paper deals with the
isolation and identification of the active constituents.
MATERIALS AND METHODS
Instruments and Reagents The instruments and reagents
used in this study are the same as those described in the pre-
vious paper.3)
Materials The seeds of R. volubilis were collected from
Ogawa Island, Saga Prefecture, Japan, in October, 1999. The
test samples of ellagic acid , dehydrodigallic acid, flavogal-
lonic acid dilactone, and tergallic acid dilactone were those
previously isolated by two authors (Tanaka and Nonaka)
from Nuphar japonicum4) and Mallotus japonicus.5) 
Extraction and Isolation The seeds (323 g) were pow-
dered and extracted with MeOH under reflux. The extract
was partitioned between EtOAc and 40% MeOH. After evap-
oration, the 40% MeOH extract was subjected to Diaion HP-
20 column chromatography using H2O and MeOH. Both
fractions were further purified by Sephadex LH-20 (50%
MeOH, MeOH) chromatography, and the antiproliferative
activity was monitored. The MeOH fraction (1.0 g) provided
gallic acid methylester (1) (130 mg) and 1,6-di-O-galloylglu-
cose (4) (30 mg), and from the H2O fraction (7.0 g), gallic
acid (2) (140 mg) and 1-O-galloylglucose (5) (70 mg) were
isolated. The EtOAc layer was concentrated and the extract
(14 g) was subjected to Sephadex LH-20 column chromatog-
raphy (CHCl3 : MeOH : H2O55 : 5 : 1) to afford four fractions
(Fr. I—IV). Since the latter three fractions showed antiprolif-
erative activity, they were further purified by the same resin
chromatography using different solvent systems. Compound
5 (240 mg) from Fr. II (1.4 g, solvent; 50%MeOH), com-
pounds 1 (2.4 g), 2 (570 mg) and 5 (130 mg) from Fr. III (4.4
g, solvent; MeOH), and trigalloylgallic acid (6) (50 mg) and
7-O-galloylcatechin (3) (280 mg) from Fr. IV (0.4 g, solvent;
EtOH) were isolated. Compounds 1—6 were identified as
gallic acid methylester, gallic acid,6) 7-O-galloylcatechin,7)
1,6-di-O-galloylglucose,6) 1-O-galloylglucose,8) and trigal-
loylgallic acid,9) respectively, by comparison of their physical
data with those reported.
Cells MK-1 was provided from Dr. M. Katano, Faculty
of Medicine, Kyushu University. HeLa and B16F10 were
supplied from the Cell Resource Center for the Biomedical
Research Institute of Development, Aging and Cancer, To-
hoku University.
Determination of Antiproliferative Activity The inhi-
bition of the cellular growth was estimated using the MTT
assay described by Mosmann.10) The detailed procedure is
shown in the previous paper.11)
RESULTS AND DISCUSSION
Bioactivity-guided fractionation of the MeOH extract of
the seeds of Rhynchosia volubilis has resulted in the isolation
of six polyphenols, 1—6 (Fig. 1).
The antiproliferative activity of each isolate was deter-
mined by the MTT assay, and their GI50 values are listed in
Table 1.
All isolates inhibited the growth of three tumor cells, and
were more potent against B16F10 than against HeLa and
MK-1. Compound 6 showed the highest activity of all, and 2
followed next. The activity of 1 and three other esters (3—5)
were less potent than that of 2. Esterification of the carboxyl
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The MeOH extract of the seeds of Rhynchosia volubilis (Leguminosae) showed antiproliferative activity
against human gastric adenocarcinoma [MK-1, 50% growth inhibition (GI50): 25 mg/ml], human uterus carci-
noma (HeLa, GI50: 30 mg/ml), and murine melanoma (B16F10, GI50: 8 mg/ml) cells. Bioactivity-guided fractiona-
tion resulted in the isolation of gallic acid methylester (1), gallic acid (2), 7-O-galloylcatechin (3), 1,6-di-O-galloyl-
glucose (4), 1-O-galloylglucose (5), and trigalloylgallic acid (6), and their antiproliferative activity was estimated.
All showed much stronger inhibition against B16F10 cell growth than against HeLa and MK-1 cell growth. Com-
pound 2 and its tetramer (6) with a free carboxyl group showed higher activity than those which did not have a
free carboxyl group. In relation to the gallic acid tetramer (6), two gallic acid dimers (ellagic acid and dehydrodi-
gallic acid) and trimers (tergallic acid dilactone and flavogallonic acid dilactone) were tested for their activity,
and compared with those of the isolates. 
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group of gallic acid reduced the activity. A similar result has
already been reported against rat hepatoma (dRLh-84) cells
by Inoue et al.12) We have also observed the phenomenon
that the antiproliferative activity of caffeic acid is lowered by
esterification.1)
In spite of structural differences, 5 and 3 showed similar
activity. Since the activity of catechin was less potent than
that of 3 (not shown), the presence of the galloyl group
would be a key factor for antiproliferative activity.
The GI50 values of 4 are slightly smaller than those of 5.
Furthermore, the GI50 value of 6, which was a tetramer of 2,
was about one-half that of 2. These data suggest that the
number of the galloyl group would be one factor for enhanc-
ing the activity, although not directly proportional.
Inoue et al. elucidated that three adjacent phenolic hy-
droxyl groups of gallic acid should be essential to the cyto-
toxicity, since the methylation (syringic acid, 4-O-methyl gal-
late) or deletion (protocatechuic acid, 3,5-dihydroxybenzoic
acid, p-hydroxybenzoic acid) of phenolic hydroxyl groups
completely removed the cytotoxicity. And a carboxyl group
is likely to be necessary in order for gallic acid to show se-
lectivity to cancer cells, since pyrogallol killed not only
dRLh-84 cells, but also primary cultured rat hepatocytes.12)
Furthermore, they also disclosed that the cell death induced
by gallic acid was accompanied by internucleosomal DNA
fragmentation characteristic of apoptosis.13)
In order to clarify in more detail the structure-antiprolifer-
ative activity relationship of gallic acid derivatives, we tested
for the antiproliferative activity of ellagic acid and three re-
lated phenol carboxylic acids (Fig. 2) which are the non-sac-
charide parts of hydrolyzable tannins. We checked the activ-
ity of two dimers of gallic acid, ellagic acid (EA) and dehy-
drodigallic acid (DA), and two trimers, flavogallonic acid di-
lactone (FAD) and tergallic acid dilactone (TAD). All inhib-
ited B16F10 cell growth, were less active against MK-1 cells,
and almost inactive toward HeLa cells.
Against our first conjecture that the number of the galloyl
group and the presence/absence of the free carboxyl group
influenced the activity, EA, a gallic acid dimer with neither a
free carboxyl group nor three adjacent phenolic hydroxyl
groups, showed almost similar activity to that of 2 against
B16F10 cells, and the activity of the other three derivatives
with the free carboxyl group were less than EA, except
against HeLa cells.
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Fig. 1. Antiproliferative Polyphenols Isolated from Rhynchosia volublis
Fig. 2. Ellagic Acid and Related Phenol Carboxylic Acids
Table 1. Antiproliferative Activity (GI50, mM) against B16F10, HeLa and
MK-1 Cell Lines
Compounds B16F10 HeLa MK-1
1 18 43 65
2 7.1 22 19
3 9.0 38 41
4 8.1 29 39
5 15 45 60
6 2.9 9.3 10
EA 10 .100 mg/ml 43
DA 12 89 47
FAD 26 .100 mg/ml 110
TAD 17 117 53
Values are the means of four determinations. EA: ellagic acid, DA: dehydrodigallic
acid, FAD: flavogallonic acid dilactone,  TAD: tergallic acid dilactone.
There might be some factors other than the numbers of the
galloyl group and the presence/absence of the free carboxyl
group for polyphenols to exhibit antiproliferative activity.
Since Inoue et al. reported that the mechanism of apoptosis
by 2 was different than that by its ester derivative (GD-1: 
3,4-methylenedioxyphenyl 3,4,5-trihydroxybenzoate),13,14) it
would be necessary to accumulate the activity data of a vari-
ety of polyphenols in order to discuss the structure-activity
relationship.
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